A teenager who lost four family members to a rare genetic condition has become the first person in Europe to receive a “life-changing” drug after it was approved for use on the NHS.
Mary Catchpole, 19, also has activated PI3-Kinase delta syndrome (APDS), a rare inherited disorder that leaves people with a significantly weakened immune system.
